(Q40598793)

English

Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber

scientific article published on March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Marieke Griffioen

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

3

object named as

Jaap Goudsmit

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Elisabeth H Slager

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Caroline E van der Minne

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Johanna M M van Oers

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Stefan Kostense

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Menzo J E Havenga

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Susanne Osanto

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

227-236

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Human tumor antigens for cancer vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Immune responses to adenovirus and adeno-associated virus in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Molecular epidemiology of adenovirus type 35 infections in immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

LAGE-1, a new gene with tumor specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Improved adenovirus vectors for infection of cardiovascular tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Priming of T cells with Ad-transduced DC followed by expansion with peptide-pulsed DC significantly enhances the induction of tumor-specific CD8+ T cells: implications for an efficient vaccination strategy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

21 January 2018

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection and quantification of CD8+ T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-?-elispot assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracellular processing and presentation of a 69-mer synthetic polypeptide to MHC class I-restricted T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700674

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700674

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40598793&oldid=2203817511"